1.5

4 trials

Sponsors

Technische Universität München, Wissenschaftszentrum Weihenstephan, Lehrstuhl für Molekulare Ernährungsmedizin, Innate Pharma, Faculdade de Ciências Farmacêuticas de Ribeirão Preto da Universidade de São Paulo, Faculdade de Ciências Farmacêuticas de Ribeirão Preto

Conditions

Cutaneous T-cell lymphomaE66 E78 K63Personal history of malignant neoplasm of breastSystemic lupus erythematosus

Phase 4

Evaluation of the contribution of lupus in the distribution of statins to the liver.

Active, not recruitingRBR-6p37zr

Faculdade de Ciências Farmacêuticas de Ribeirão Preto da Universidade de São PauloSystemic lupus erythematosus

Start: 2016-02-01Updated: 2025-10-27

Unknown Phase

Open label, multicenter phase I study of IPH4102, a humanized anti-KIR3DL2 monoclonal antibody, in patients with relapsed/refractory cutaneous T-cell lymphomas (CTCL)

Active, not recruitingNL-OMON44047

Innate PharmaCutaneous T-cell lymphoma

Start: 2016-11-22Target: 6Updated: 2024-04-23

Clinical pharmacology of tamoxifen in breast cancer patients

Active, not recruitingRBR-7tqc7k

Faculdade de Ciências Farmacêuticas de Ribeirão PretoPersonal history of malignant neoplasm of breast

Start: 2015-01-07Updated: 2025-10-27

The impact of dietary cholesterol and the gut microbiota on the intestinal lipid resorption and the systemic lipid metabolism

Active, not recruitingDRKS00020788

Technische Universität München, Wissenschaftszentrum Weihenstephan, Lehrstuhl für Molekulare ErnährungsmedizinE66 E78 K63

Start: 2022-04-04Target: 10Updated: 2025-04-07

Related Papers

Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients.

2019-12-1916 citations